307 related articles for article (PubMed ID: 23062024)
21. A novel FK506 loaded nanomicelles consisting of amino-terminated poly(ethylene glycol)-block-poly(D,L)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery.
Liu D; Wu Q; Chen W; Lin H; Zhu Y; Liu Y; Liang H; Zhu F
Int J Pharm; 2019 May; 562():1-10. PubMed ID: 30878586
[TBL] [Abstract][Full Text] [Related]
22. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.
Cho Y; Ha ES; Baek IH; Kim MS; Cho CW; Hwang SJ
Molecules; 2015 May; 20(6):9496-509. PubMed ID: 26020699
[TBL] [Abstract][Full Text] [Related]
23. Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique.
Jang SW; Kang MJ
Int J Pharm; 2014 Oct; 473(1-2):187-93. PubMed ID: 25003829
[TBL] [Abstract][Full Text] [Related]
24. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
Gao P; Akrami A; Alvarez F; Hu J; Li L; Ma C; Surapaneni S
J Pharm Sci; 2009 Feb; 98(2):516-28. PubMed ID: 18543293
[TBL] [Abstract][Full Text] [Related]
25. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
[TBL] [Abstract][Full Text] [Related]
26. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
27. Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailability.
Tsunashima D; Yamashita K; Ogawara KI; Sako K; Hakomori T; Higaki K
J Pharm Pharmacol; 2017 Dec; 69(12):1697-1706. PubMed ID: 28872687
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
Wang Y; Han X; Wang J; Wang Y
Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
[TBL] [Abstract][Full Text] [Related]
29. Effect of Soluplus on the supersaturation and absorption of tacrolimus formulated as inclusion complex with dimethyl-β-cyclodextrin.
Tao C; Huo T; Zhang Q; Song H
Pharm Dev Technol; 2019 Nov; 24(9):1076-1082. PubMed ID: 31180797
[TBL] [Abstract][Full Text] [Related]
30. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
Hussein A; El-Menshawe S; Afouna M
Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
[TBL] [Abstract][Full Text] [Related]
32. Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.
Nekkanti V; Rueda J; Wang Z; Betageri GV
AAPS PharmSciTech; 2016 Oct; 17(5):1019-29. PubMed ID: 26729532
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect.
Choi Y; Min KA; Kim CK
Drug Dev Ind Pharm; 2019 Jun; 45(6):895-904. PubMed ID: 30889990
[TBL] [Abstract][Full Text] [Related]
34. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
Wang Y; Sun J; Zhang T; Liu H; He F; He Z
Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
[TBL] [Abstract][Full Text] [Related]
35. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
Miller JM; Beig A; Carr RA; Spence JK; Dahan A
Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
[TBL] [Abstract][Full Text] [Related]
36. Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.
Beak IH; Kim MS
Chem Pharm Bull (Tokyo); 2012; 60(11):1468-73. PubMed ID: 23124571
[TBL] [Abstract][Full Text] [Related]
37. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
[TBL] [Abstract][Full Text] [Related]
39. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
Suys EJA; Chalmers DK; Pouton CW; Porter CJH
Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
[TBL] [Abstract][Full Text] [Related]
40. Investigating the Impact of Drug Crystallinity in Amorphous Tacrolimus Capsules on Pharmacokinetics and Bioequivalence Using Discriminatory In Vitro Dissolution Testing and Physiologically Based Pharmacokinetic Modeling and Simulation.
Purohit HS; Trasi NS; Sun DD; Chow ECY; Wen H; Zhang X; Gao Y; Taylor LS
J Pharm Sci; 2018 May; 107(5):1330-1341. PubMed ID: 29289674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
